273 related articles for article (PubMed ID: 19590243)
1. Soluble fas antigen and soluble fas ligand in intrauterine growth restriction.
Briana DD; Baka S; Boutsikou M; Liosi S; Vraila VM; Gourgiotis D; Hassiakos D; Malamitsi-Puchner A
Neonatology; 2010; 97(1):31-5. PubMed ID: 19590243
[TBL] [Abstract][Full Text] [Related]
2. Circulating osteoprotegerin and sRANKL concentrations in the perinatal period at term. The impact of intrauterine growth restriction.
Briana DD; Boutsikou M; Baka S; Hassiakos D; Gourgiotis D; Malamitsi-Puchner A
Neonatology; 2009; 96(2):132-6. PubMed ID: 19365143
[TBL] [Abstract][Full Text] [Related]
3. Perinatal bone turnover in term pregnancies: the influence of intrauterine growth restriction.
Briana DD; Gourgiotis D; Boutsikou M; Baka S; Hassiakos D; Vraila VM; Creatsas G; Malamitsi-Puchner A
Bone; 2008 Feb; 42(2):307-13. PubMed ID: 18024242
[TBL] [Abstract][Full Text] [Related]
4. Omentin-1 and vaspin are present in the fetus and neonate, and perinatal concentrations are similar in normal and growth-restricted pregnancies.
Briana DD; Boutsikou M; Baka S; Gourgiotis D; Marmarinos A; Liosi S; Hassiakos D; Malamitsi-Puchner A
Metabolism; 2011 Apr; 60(4):486-90. PubMed ID: 20488498
[TBL] [Abstract][Full Text] [Related]
5. Soluble vascular endothelial growth factor receptor-1 in intrauterine growth restricted fetuses and neonates.
Boutsikou T; Malamitsi-Puchner A; Economou E; Boutsikou M; Puchner KP; Hassiakos D
Early Hum Dev; 2006 Apr; 82(4):235-9. PubMed ID: 16337100
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the maternal and umbilical vein serum sFas/sFasL system in pregnancies complicated by preeclampsia with intrauterine growth retardation.
Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
Eur J Obstet Gynecol Reprod Biol; 2006 Jun; 126(2):155-9. PubMed ID: 16169656
[TBL] [Abstract][Full Text] [Related]
7. Serum fetuin-A/alpha2-HS-glycoprotein in human pregnancies with normal and restricted fetal growth.
Briana DD; Boutsikou M; Gourgiotis D; Boutsikou T; Baka S; Marmarinos A; Hassiakos D; Malamitsi-Puchner A
J Matern Fetal Neonatal Med; 2008 Nov; 21(11):826-30. PubMed ID: 19031279
[TBL] [Abstract][Full Text] [Related]
8. Intrauterine growth restriction may not suppress bone formation at term, as indicated by circulating concentrations of undercarboxylated osteocalcin and Dickkopf-1.
Briana DD; Gourgiotis D; Georgiadis A; Boutsikou M; Baka S; Marmarinos A; Hassiakos D; Malamitsi-Puchner A
Metabolism; 2012 Mar; 61(3):335-40. PubMed ID: 21944272
[TBL] [Abstract][Full Text] [Related]
9. Serum cystatin C in pregnancies with normal and restricted fetal growth.
Malamitsi-Puchner A; Briana DD; Kontara L; Boutsikou M; Baka S; Hassiakos D; Marmarinos A; Gourgiotis D
Reprod Sci; 2007 Jan; 14(1):37-42. PubMed ID: 17636214
[TBL] [Abstract][Full Text] [Related]
10. Perinatal changes of plasma resistin concentrations in pregnancies with normal and restricted fetal growth.
Briana DD; Boutsikou M; Baka S; Gourgiotis D; Marmarinos A; Hassiakos D; Malamitsi-Puchner A
Neonatology; 2008; 93(3):153-7. PubMed ID: 17878741
[TBL] [Abstract][Full Text] [Related]
11. The effect of intrauterine growth restriction on circulating surfactant protein D concentrations in the perinatal period.
Briana DD; Gourgiotis D; Baka S; Boutsikou M; Vraila VM; Boutsikou T; Hassiakos D; Malamitsi-Puchner A
Reprod Sci; 2010 Jul; 17(7):653-8. PubMed ID: 20360592
[TBL] [Abstract][Full Text] [Related]
12. Perinatal collagen turnover markers in intrauterine growth restriction.
Gourgiotis D; Briana DD; Georgiadis A; Boutsikou M; Baka S; Marmarinos A; Hassiakos D; Malamitsi-Puchner A
J Matern Fetal Neonatal Med; 2012 Sep; 25(9):1719-22. PubMed ID: 22339296
[TBL] [Abstract][Full Text] [Related]
13. Serum Beta-2-microglobulin levels in intrauterine growth-restricted and normal pregnancies.
Kontara L; Briana DD; Baka S; Boutsikou M; Marmarinos A; Gourgiotis D; Malamitsi-Puchner A
Fetal Diagn Ther; 2008; 24(3):220-4. PubMed ID: 18753761
[TBL] [Abstract][Full Text] [Related]
14. Serum Bcl-2, caspase-9 and soluble FasL levels as perinatal markers in late preterm pregnancies with intrauterine growth restriction.
Genç ŞÖ; Karakuş S; Çetin A; Çetin M; Doğan HO; Korgalı EÜ
Turk J Pediatr; 2019; 61(5):686-696. PubMed ID: 32105000
[TBL] [Abstract][Full Text] [Related]
15. Fetal concentrations of the growth factors TGF-α and TGF-β1 in relation to normal and restricted fetal growth at term.
Briana DD; Liosi S; Gourgiotis D; Boutsikou M; Marmarinos A; Baka S; Hassiakos D; Malamitsi-Puchner A
Cytokine; 2012 Oct; 60(1):157-61. PubMed ID: 22732125
[TBL] [Abstract][Full Text] [Related]
16. Soluble Fas and Fas-ligand levels in mid-trimester amniotic fluid and their associations with severe small for gestational age fetuses: a prospective observational study.
Vrachnis N; Dalainas I; Papoutsis D; Samoli E; Rizos D; Iliodromiti Z; Siristatidis C; Tsikouras P; Creatsas G; Botsis D
J Reprod Immunol; 2013 Jun; 98(1-2):39-44. PubMed ID: 23582102
[TBL] [Abstract][Full Text] [Related]
17. Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure.
Perianayagam MC; Murray SL; Balakrishnan VS; Guo D; King AJ; Pereira BJ; Jaber BL
J Lab Clin Med; 2000 Oct; 136(4):320-7. PubMed ID: 11039853
[TBL] [Abstract][Full Text] [Related]
18. Perinatal changes of circulating N-terminal pro B-type natriuretic peptide (NT-proBNP) in normal and intrauterine-growth-restricted pregnancies.
Iacovidou N; Briana DD; Boutsikou M; Gourgiotis D; Baka S; Vraila VM; Hassiakos D; Malamitsi-Puchner A
Hypertens Pregnancy; 2007; 26(4):463-71. PubMed ID: 18066964
[TBL] [Abstract][Full Text] [Related]
19. Intrauterine growth restriction and circulating neurotrophin levels at term.
Malamitsi-Puchner A; Nikolaou KE; Economou E; Boutsikou M; Boutsikou T; Kyriakakou M; Puchner KP; Hassiakos D
Early Hum Dev; 2007 Jul; 83(7):465-9. PubMed ID: 17071024
[TBL] [Abstract][Full Text] [Related]
20. Intrauterine growth restriction is associated with changes in polyunsaturated fatty acid fetal-maternal relationships.
Cetin I; Giovannini N; Alvino G; Agostoni C; Riva E; Giovannini M; Pardi G
Pediatr Res; 2002 Nov; 52(5):750-5. PubMed ID: 12409524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
